According to the 2015 ESC/ERS guidelines, the presence of a biallelic EIF2AK4 mutation is sufficient to confirm the diagnosis of PVOD without additional histological confirmation [2]. The gene discussed is EIF2AK4; the disease is pulmonary venoocclusive disease.